Truist Financial’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,125
Closed -$299K 2795
2021
Q3
$299K Buy
+4,125
New +$298K ﹤0.01% 2357

Other funds holding NBP

Truist Financial's NBP Position: Q4 2021 in Review

Truist Financial sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2021, closing a stake of 4,125 shares — an estimated $299K sold.

Truist Financial first reported a position in NBP in Q3 2021 and held it in 1 quarter. The position peaked at $299K in Q3 2021. 132 funds tracked by Wall St. Rank hold NBP as of Q4 2021.

  • Truist Financial reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Truist Financial sold 4,125 NovaBridge Biosciences American Depositary Shares shares in Q4 2021, an estimated $299K.
  • Truist Financial first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 1 quarter.
  • Truist Financial's NovaBridge Biosciences American Depositary Shares position peaked at $299K in Q3 2021.
  • 132 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2021.

Based on Truist Financial's 13F filing for Q4 2021, filed 14 Feb 2022.